Consumer Feels Like...
Health Care: Drugs
Ariad Pharmaceuticals (ARIA: NASDAQ)
$15.14 -0.08 | -0.53%
02/09/12 - 02:10 PM ET
1.66M / 3.21M
Vol / Avg. Vol:15.26 / 15.22
Open / Prev. Close:14.88 - 15.38
Today's Range:5.52 - 15.98
52 Wk Range:24.24%
Performance YTD:TheStreet Rating:
Portfolios with ARIA
- Portfolio NameUser Type
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Biotech Stocks Loved and...
- ContributorEarnings Short Squeeze Play...
- Contributor5 Stocks Under-$10 Setting ...
- Userlance and donna
- ContributorHot Biotech Trades for Seco...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorCancer Drug Stocks to Trade...
Latest ARIA Headlines from TheStreet
- Ariad Reaches New 52-Week High (ARIA) 02.03.12 | 03:02 pm
- Ariad Stock Hits New 52-Week High (ARIA) 01.25.12 | 04:01 pm
- Ariad Reaches New 52-Week High (ARIA) 01.17.12 | 08:01 am
- J.P. Morgan Biotech Confab Live Chat 01.10.12 | 06:01 pm
- 8 Stocks Hitting New Highs Today 01.06.12 | 12:01 pm
- Ariad Reaches New 52-Week High (ARIA) 01.06.12 | 10:01 am
- Ariad Rises On Unusually High Volume (ARIA) 12.15.11 | 04:12 pm
- 6 Stocks Rising on Huge Volume 12.15.11 | 01:12 pm
- The Best Biotech CEO of 2011 Is ... 12.14.11 | 06:12 am
- Onyx Trips, Ariad and Pharmacyclics Shine at Blood Cancer Meeting 12.12.11 | 07:12 am
Press Releases for ARIA
- ARIAD To Present At Upcoming Investor Conferences - Business Wire 02.02.12 | 07:02 am
- ARIAD To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 07:01 am
- ARIAD To Trade On The NASDAQ Global Select Market - Business Wire 01.03.12 | 07:01 am
- ARIAD Announces Completion Of Public Offering - Business Wire 12.20.11 | 04:12 pm
- ARIAD Announces Underwriters’ Exercise Of Over-Allotment Option - Business Wire 12.16.11 | 09:12 am
- ARIAD Announces Pricing Of Public Offering Of Common Stock - Business Wire 12.15.11 | 09:12 am
- ARIAD Announces Proposed Public Offering Of Common Stock - Business Wire 12.14.11 | 04:12 pm
- ARIAD Announces Preliminary Data From Pivotal Pace Trial Of Ponatinib, Its Investigational Pan-BCR-ABL Inhibitor - Business Wire 12.11.11 | 07:12 pm
- ARIAD To Present At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.06.11 | 07:12 am
- ARIAD Announces Investor Meeting And Webcast At American Society Of Hematology Meeting - Business Wire 12.05.11 | 07:12 am
Partner Headlines for ARIA
- Notable Put Options Activity in ARIAD Pharmaceuticals - Benzinga 02.02.12 | 01:02 pm
- Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012 - Seeking Alpha 01.27.12 | 09:01 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Using Friday's Option Trades To Find Investment Ideas - Seeking Alpha 01.13.12 | 06:01 pm
- YM's Positive Results Have Incyte Investors Worried - Seeking Alpha 12.15.11 | 09:12 am
- Rodman & Renshaw Maintain Market Outperform Rating and $15 PT on ARIAD Pharmaceuticals - Benzinga 11.01.11 | 09:11 am
- 5 Stocks Under $10: Are These Shares Undervalued? - Seeking Alpha 10.14.11 | 09:10 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.04.11 | 09:10 am
- Stocks Rebound; Euro Concerns Ease While New Home Sales, Gold Slip - NASDAQ 09.26.11 | 04:09 pm
- Mid-Day Update: Stocks Advance Amid Easing Concern Over Europe's Debt Picture; Gold Slumps - NASDAQ 09.26.11 | 04:09 pm
